These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3120144)

  • 1. Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation.
    Nishida N; Sugimoto T; Araki A; Woo M; Sakane Y; Kobayashi Y
    Pediatr Res; 1987 Nov; 22(5):500-3. PubMed ID: 3120144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine metabolism and morphometric change of liver mitochondria in valproate-treated rats.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y; Sakane Y
    Neuropediatrics; 1990 Nov; 21(4):187-90. PubMed ID: 2290478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-carnitine replacement therapy in chronic valproate treatment.
    Melegh B; Kerner J; Acsádi G; Lakatos J; Sándor A
    Neuropediatrics; 1990 Feb; 21(1):40-3. PubMed ID: 2107456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y
    J Child Neurol; 1992 Oct; 7(4):404-7. PubMed ID: 1469250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
    Knapp AC; Todesco L; Beier K; Terracciano L; Sägesser H; Reichen J; Krähenbühl S
    J Pharmacol Exp Ther; 2008 Feb; 324(2):568-75. PubMed ID: 17986647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues.
    Rozas I; Camiña MF; Paz JM; Alonso C; Castro-Gago M; Rodriguez-Segade S
    Biochem Pharmacol; 1990 Jan; 39(1):181-5. PubMed ID: 2105093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity in rat following administration of valproic acid.
    Sugimoto T; Woo M; Nishida N; Takeuchi T; Sakane Y; Kobayashi Y
    Epilepsia; 1987; 28(2):142-6. PubMed ID: 3102219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid.
    Arslan M; Vurucu S; Balamtekin N; Unay B; Akin R; Kurt I; Ozcan O
    Brain Dev; 2009 Jun; 31(6):405-10. PubMed ID: 18814980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy.
    Beghi E; Bizzi A; Codegoni AM; Trevisan D; Torri W
    Epilepsia; 1990; 31(3):346-52. PubMed ID: 2111771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity in rat following administration of valproic acid: effect of L-carnitine supplementation.
    Sugimoto T; Araki A; Nishida N; Sakane Y; Woo M; Takeuchi T; Kobayashi Y
    Epilepsia; 1987; 28(4):373-7. PubMed ID: 3113926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Carnitine on Valproic Acid Pharmacokinetics in Rats.
    Katayama H; Mizukami K; Yasuda M; Hatae T
    J Pharm Sci; 2016 Oct; 105(10):3199-3204. PubMed ID: 27499337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency.
    Tein I; DiMauro S; Xie ZW; De Vivo DC
    Pediatr Res; 1993 Sep; 34(3):281-7. PubMed ID: 8134167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the cytotoxicity of sodium valproate on primary cultured rat hepatocytes.
    Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
    Neuropediatrics; 1988 Aug; 19(3):158-61. PubMed ID: 3146709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.
    Camiña MF; Rozas I; Gómez M; Paz JM; Alonso C; Rodriguez-Segade S
    Br J Pharmacol; 1991 May; 103(1):1179-83. PubMed ID: 1878756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
    Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E
    Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
    Anil M; Helvaci M; Ozbal E; Kalenderer O; Anil AB; Dilek M
    J Child Neurol; 2009 Jan; 24(1):80-6. PubMed ID: 19168820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.